NContact scores 510(k) clearance for next-gen cardiac system

01/24/2013 | MassDevice.com (Boston)

The FDA has cleared nContact to market EPi-Sense, a next-generation version of the company's VisiTrax heart ablation system. The newly cleared technology comes with advanced sensors, which transmit electrical signals to help electrophysiologists position the device better when performing cardiac ablation surgery.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA